These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34285919)

  • 61. The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
    Magnes T; Melchardt T; Hufnagl C; Weiss L; Mittermair C; Neureiter D; Klieser E; Rinnerthaler G; Roesch S; Gaggl A; Greil R; Egle A
    Pharmacogenomics J; 2018 May; 18(3):474-479. PubMed ID: 28719596
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.
    Yao Y; Wang D; Zhang Y; Tang Q; Xu Z; Qin L; Qu Y; Yan Z
    J Gene Med; 2024 Jan; 26(1):e3605. PubMed ID: 37932968
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer.
    Feng B; Shen Y; Pastor Hostench X; Bieg M; Plath M; Ishaque N; Eils R; Freier K; Weichert W; Zaoui K; Hess J
    Clin Cancer Res; 2020 Jul; 26(14):3616-3628. PubMed ID: 32161122
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The characteristics and clinical relevance of tumor fusion burden in head and neck squamous cell carcinoma.
    He L; Ren D; Lv G; Mao B; Wu L; Liu X; Gong L; Liu P
    Cancer Med; 2023 Jan; 12(1):852-861. PubMed ID: 35621268
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The analysis of tumor-infiltrating immune cell and ceRNA networks in laryngeal squamous cell carcinoma.
    Li D; Dong K; Su J; Xue H; Tian J; Wu Y; Wang J
    Medicine (Baltimore); 2022 Aug; 101(31):e29555. PubMed ID: 35945754
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma.
    Tan M; Lin X; Chen H; Ye W; Yi J; Li C; Liu J; Su J
    PeerJ; 2023; 11():e15203. PubMed ID: 37090107
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
    Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
    Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
    Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
    Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment.
    Ding Q; Lin F; Huang Z; Li Y; Cai S; Chen X; Liu H; Qiu S
    Sci Rep; 2024 Feb; 14(1):4426. PubMed ID: 38396056
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive analysis of INHBA: A biomarker for anti-TGFβ treatment in head and neck cancer.
    Zhang S; Jin K; Li T; Zhou M; Yang W
    Exp Biol Med (Maywood); 2022 Aug; 247(15):1317-1329. PubMed ID: 35521936
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis.
    Huang C; Liu J
    Genet Res (Camb); 2022; 2022():6880760. PubMed ID: 36636556
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway.
    Jia W; Chen S; Wei R; Yang X; Zhang M; Qian Y; Liu H; Lei D
    Sci Rep; 2023 Jul; 13(1):10956. PubMed ID: 37414830
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RNA splicing regulator EIF3D regulates the tumor microenvironment through immunogene-related alternative splicing in head and neck squamous cell carcinoma.
    Lu D; Mihoayi M; Ablikim Y; Arikin A
    Aging (Albany NY); 2024 Mar; 16(7):5929-5948. PubMed ID: 38535990
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spermine synthase (
    Pan X; Xue L; Sun Y
    Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
    Hu C; Fan J; He G; Dong C; Zhou S; Zheng Y
    PLoS One; 2022; 17(6):e0269166. PubMed ID: 35653344
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
    Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H
    BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bioinformatics analysis of DNMT1 expression and its role in head and neck squamous cell carcinoma prognosis.
    Cui J; Zheng L; Zhang Y; Xue M
    Sci Rep; 2021 Jan; 11(1):2267. PubMed ID: 33500531
    [TBL] [Abstract][Full Text] [Related]  

  • 80. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
    Fan L; Zhang A; Deng P
    Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.